Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.92 USD | -14.02% | -23.33% | +55.93% |
07:22pm | Durect Far From Earnings Story But FDA Commentary Shows Path Forward, Oppenheimer Says | MT |
May. 13 | Transcript : DURECT Corporation, Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.93% | 33.21M | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- DRRX Stock
- News DURECT Corporation
- Transcript : DURECT Corporation - Shareholder/Analyst Call